Seagen (NASDAQ:SGEN) shares are trading higher after the company, along with Genmab A/S (NASDAQ:GMAB), announced the FDA has granted accelerated approval to TIVDAKTM for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Seagen's stock is trading up 6.2% to a price of $168.92. The stock's current volume for the day is 365.81 thousand, which is approximately 55.63% of its previous 30-day average volume of 657.62 thousand.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
The moving average price of the stock over the past 50 days was $154.51 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $213.94 and as low as $133.2.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.